by embracemarketing | Sep 30, 2024 | BLOG
ESMO 2024 ran from Sept 13-17 in Barcelona, Spain, where the top oncology players came together to share the latest data across tumor types and MOAs. Below, Adelphi explores select hot topics, including ADCs in bladder cancer, TIGITs and bispecific antibodies, and...
by embracemarketing | Sep 18, 2024 | BLOG
The European Association for the Study of Diabetes (EASD) conference is a key event where groundbreaking research and advancements in diabetes care are presented. This year, three hot topics stood out: the competition between once-weekly insulins, the ongoing...
by embracemarketing | Jul 31, 2024 | BLOG
If you’re a EPHMRA member and couldn’t attend you can access the conference videos here. If you would like more information get in touch with Ben Walker, Research Director at Adelphi Research – [email protected]. The importance of patient...
by embracemarketing | Jul 3, 2024 | BLOG
Biotech takes on chronic weight management As Novo Nordisk and Lilly generate massive profits with weight-loss blockbusters Wegovy and Zepbound, several smaller players are looking to develop novel solutions that address some of the challenges with currently marketed...
by embracemarketing | Jun 12, 2024 | BLOG
ASCO 2024 ran from May 31-June 4 in Chicago, IL, bringing together physicians, academics, and industry to share data and discuss cutting edge treatments in oncology. Below, Adelphi’s Oncology Task Force breaks down key news from some of the biggest players in...
by embracemarketing | Jun 12, 2024 | BLOG
There are many possible answers to a challenge, depending on how you look at the problem. At Adelphi Research, we are firm believers in the value of looking at problems through multiple lenses and utilising different perspectives to uncover truly brilliant solutions....
Recent Comments